Why Rare Disease Patients Fight So Hard for Clinical Trials
Written By Sara Mazzilli
Why Clinical Trials Matter — Journalist and rare disease advocate Lindsay Guentzel breaks down why clinical trials are a lifeline for the rare disease community. With only 5% of known rare diseases having an FDA-approved therapy, trials often represent the only path toward treatment, progress, and hope.
Navigating rare disease care can be exceptionally complex. If you are interested in learning more about the latest research opportunities in your rare disease, you can contact the Know Rare Support Team at support@knowrare.com.
Latest from Know Rare
Blog v2
